7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline has been researched along with EHS Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hodgkiss, RJ; Webster, L; Wilson, GD | 3 |
3 other study(ies) available for 7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline and EHS Tumor
| Article | Year |
|---|---|
Development of bioreductive markers for tumour hypoxia.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Caffeine; Carcinoma; Cell Division; Cell Hypoxia; Cell Line; DNA, Neoplasm; Mice; Mice, Inbred CBA; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Theophylline; Tumor Cells, Cultured | 1995 |
Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Hypoxia; Mice; Neoplasms, Experimental; Nitroimidazoles; Sarcoma, Experimental; Theophylline | 1998 |
Measurement of hypoxia in vivo using a 2-nitroimidazole (NITP).
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Mammary Neoplasms, Experimental; Mice; Nitroimidazoles; Oxygen; Respiration; Sarcoma, Experimental; Theophylline | 1997 |